Elecsys® ProGRP
... cuantización (≤30% error total). Referencias bibliográficas American Cancer Society - What is Lung Cancer ... . Disponible en https://www.cancer.org/cancer/ lung-cancer/about/what-is.html. Último acceso en julio de 2020 ... Cancer Society - What is Lung Cancer. Disponible en https://www.cancer.org/cancer/ lung-cancer/about/what ... Small Cell Lung Cancer.A Single Center Experience. The International Journal of BiologicalMarkers Hyung ...
Prueba VENTANA ALK (D5F3) CDx (aprobada por la FDA de los EE. UU.)
... . Fecha de acceso: 1 de agosto de 2014. 6. Lung Cancer Survival Rates and Prognosis. National Cancer ... Institute at the National Institutes of Health. Bethesda, MD. http://www.cancer.gov/cancertopics/types/ lung ... . Fecha de acceso: 1 de agosto de 2014. 6. Lung Cancer Survival Rates and Prognosis. National Cancer ... Institute at the National Institutes of Health. Bethesda, MD. http://www.cancer.gov/cancertopics/types/ lung ...
Anticuerpo primario monoclonal de conejo contra ALK (D5F3) VENTANA ...
... . 6. Lung Cancer Survival Rates and Prognosis. National Cancer Institute at the National Institutes of ... Health. Bethesda, MD. http://www.cancer.gov/cancertopics/types/ lung/cancer-survival-prognosis Fecha de ... . Fecha de acceso: 1 de agosto de 2014. 6. Lung Cancer Survival Rates and Prognosis. National Cancer ... Institute at the National Institutes of Health. Bethesda, MD. http://www.cancer.gov/cancertopics/types/ lung ...
Lipoproteína Tina-quant® (a) Gen. 2
... , S. (2003). Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and ... ., Koschinsky, M.L., Albers, J.J., Skarlatos, S. (2003). Report of the National Heart, Lung, and Blood Institute ... the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease ... ., Koschinsky, M.L., Albers, J.J., Skarlatos, S. (2003). Report of the National Heart, Lung, and Blood Institute ...
Carcinoma pulmonar
... https://diagnostics.roche.com/es/es/products/product-category/ lung-cancer.html ... sanitario Carcinoma pulmonar Lung cancer is the most common cancer worldwide. 1 Cáncer de pulmón Oncology ...
Infecciones transmitidas por trasplante
... . Almaghrabi RS, Omrani AS, Memish ZA. Cytomegalovirus infection in lung transplant recipients. Expert Rev ... lung transplant recipients. Expert Rev Respir Med. 2017;11(5):377-383. Vanichanan J, Udomkarnjananun S ...
Prueba de mutación de EGFR cobas® v2
... v2 Heeke S et al, Clinical Lung Cancer 2019, https:// doi.org/10.1016/j.cllc.2019.07.010 Keppens C ... . Referencias bibliográficas Prospecto de la prueba de mutación del EGFR cobas v2 Heeke S et al, Clinical Lung ...
Prueba VENTANA PD-L1 (SP142)
... ) indicaciones como diagnóstico complementario Indication for use Therapy Cutoff Non-small cell lung cancer ...
Panel de IHQ de carcinoma pulmonar de Roche
... Differential Diagnosis of Squamous Cell Carcinoma and Adenocarcinoma of the Lung. USCAP Abstract. 2013 Vogt ... Immunohistochemical Analysis of a Newly Developed, Mouse Monoclonal p40 (BC28) Antibody in Lung, Bladder, Skin, Breast ... https://diagnostics.roche.com/es/es/products/tests/ lung-cancer-ihc-ish-portfolio.html ... Adenocarcinoma of the Lung. USCAP Abstract. 2013 Vogt, Adam P, Cynthia Cohen, Momin T Siddiqui. [436] p40 (ΔNp63 ...
